Hjem › Prostatakreft › Arizona › Scottsdale
Kliniske studier for Prostatakreft i Scottsdale, AZ
17 studier for Prostatakreft søker deltakere på steder i og rundt Scottsdale (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
RekruttererFase 3
- Mayo Clinic in Arizona, Scottsdale
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- Mayo Clinic in Arizona, Scottsdale
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
RekruttererFase 3
- Mayo Clinic, Scottsdale
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RekruttererFase 3
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Scottsdale
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
RekruttererFase 2
- Mayo Clinic in Arizona, Scottsdale
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
RekruttererFase 2/3
- Honor Health Research Institute, Scottsdale
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Rekrutterer
- Mayo Clinic, Scottsdale
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
RekruttererFase 1
- HonorHealth, Scottsdale
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
RekruttererFase 1/2
- Honor Health Research Institute, Scottsdale
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Honor Health, Scottsdale
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
RekruttererFase 2
- HonorHealth Research Institute, Scottsdale
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
RekruttererTidlig fase 1
- Mayo Clinic in Arizona, Scottsdale
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
RekruttererFase 1/2
- Honor Health, Scottsdale
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
RekruttererFase 4
- Mayo Clinic Arizona, Scottsdale
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruttererFase 1
- HonorHealth Research Institute, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RekruttererFase 4
- Scottsdale Medical Imaging, LLC, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Scottsdale
Prostatakreft-studier i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN43 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Scottsdale
- Brystkreft18 studier
- Kreft (alle typer)18 studier
- Metastatisk kreft17 studier
- Kolorektal kreft16 studier
- Ikke-småcellet lungekreft15 studier
- Pankreaskreft13 studier
- Melanom10 studier
- Ulcerøs kolitt8 studier
- Lungekreft8 studier
- Leverkreft (hepatocellulært karcinom)7 studier
- Alzheimers sykdom7 studier
- Tripelnegativ brystkreft7 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.